Antibiotics therapy by superselective intra-arterial infusion for osteomyelitis of the jaw.

Antibiotics therapy by superselective intra-arterial infusion for osteomyelitis of the jaw. - Intra-arterial antibiotics infusion for osteomyelitis of the jaw

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000024897

Enrollment

Registered

2016-11-18

Start date

2016-04-06

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteomyelitis of the jaw

Interventions

4-week Intra-arterial antibiotics infusion

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Ordinal-drug therapy-resistent Osteomyelitis by microorganism infection

Exclusion criteria

Exclusion criteria: Osteoradionecrosis Medication related osteonecrosis of the jaw

Design outcomes

Primary

Measure	Time frame
Disappearance of images indicating osteomyelitis one year after drug infusion.	—

Countries

Japan

Contacts

Public ContactMakoto Hirota

Yokohama City University Oral and Maxillofacial Surgery

mhirota@yokohama-cu.ac.jp045-787-2800

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026